Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis: A GISC study

American Journal of Gastroenterology

Volumn 96, Issue 8, 2001, Pages 2407-2412

  Annese, Vito ^a   Andreoli, A ^b   Andriulli, A ^a   D'inca' R ^c   Gionchetti, P ^d   Latiano, A ^a   Lombardi, G ^a   Piepoli, A ^a   Poulain, D ^e   Sendid, B ^e   Colombel, J F ^e  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGUS ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HISTORY; FEMALE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; ANTIBODIES, FUNGAL; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COLITIS, ULCERATIVE; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SACCHAROMYCES CEREVISIAE; STATISTICS, NONPARAMETRIC;

EID: 0034885938     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02606-5     Document Type: Article

References (29)

1. The genetic background of inflammatory bowel disease
2. Inflammatory bowel disease: Progress toward a gene
3. Inflammatory bowel disease
4. Mapping of a susceptibility locus for Crohn's disease on chromosome 16
5. Two stage genome-wide search in inflammatory bowel disease: Possible evidence for susceptibility loci on chromosome 3, 7, and 12
6. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: Evidence for epistasis between 1p and IBD1
7. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort
8. A genome-wide search identifies new susceptibility loci for Crohn's disease
9. High density genome scan in Crohn disease shows confirmed linkage to the chromosome 14q11-12
10. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci
11. Inflammatory bowel disease: Etiology and pathogenesis
12. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease
13. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease
14. Classification of inflammatory bowel disease
15. Inflammatory bowel disease
16. Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus. A GISC study
17. Specific antibody response to oligomannosidic epitopes in Crohn's disease
18. Anti-Saccharomycis cerevisiae mannan combined with antineutrophil antibodies in IBD. Prevalence and diagnostic role
19. Advances in statistical methodology for the evaluation of diagnostic and laboratory tests
20. Antibody to Saccharomyces cerevisiae (baker's yeast) in Crohn's disease
21. Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease. Is IgA antibody a marker for Crohn's disease?
22. Antobody to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance
23. Antibody (IgG, IgA, and IgM) to baker's yeast mannan, gliadin, ovalbumin, and betalactoglobulin in monozigotic twins with 1BD
24. Diagnostic accuracy of serological assays in pediatric IBD
25. Marker antibody expression stratifies Crohn's disease into immunologically homogenous subgroups with distinct clinical characteristics
26. Utility of perinuclear anti-neutrophil cytoplasmic antibodies (pANCA), anti-Saccharomyces (ASCA), anti-pancreatic antibodies (APA) as serological markers in a population based cohort of patients with Crohn's disease (CD) and ulcerative colitis (UC)
27. Familial aggregation of inflammatory bowel disease in Northern Italy: A multicenter study
28. ASCA, and pANCA prevalence in mixed-IBD families